Plunkett Research Online: Bioanalytical Systems Inc

BIOANALYTICAL SYSTEMS INC (BASI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Bioanalytical Systems, Inc. (BASi) is a contract research organization (CRO) that provides drug discovery and development services to the pharmaceutical industry. BASi also sells analytical instruments to the pharmaceutical development and contract research industries, enabling drug developers to b.....



Bioanalytical Systems Inc
Ticker: BASI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 765 463-4527
Fax: 765 497-1102
Address: 2701 Kent Avenue
West Lafayette, IN 47906 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contract Research Services
Screening & Testing Services
Bioanalytical Instruments
Immunochemistry
Toxicology Testing
Formulation Development
Testing Equipment
1. IQVIA Holdings Inc10,412,000,000
2. Syneos Health Inc4,390,116,000
3. PRA Health Sciences Inc2,871,922,000
4. ICON plc2,595,777,000
5. Charles River Laboratories International Inc2,266,096,000
6. PAREXEL International Corporation2,221,000,000
7. Albany Molecular Research Inc630,000,000
8. EPS Holdings610,056,800
9. BGI Genomics336,797,000
10. Galapagos NV325,974,200
16. Bioanalytical Systems Inc26,346,000
Contacts Description
Daniel Oakley
Robert LeasureCEO/Director/President
Jill BlumhoffCFO/Chief Accounting Officer/Secretary/Vice President, Divisional
Gregory DavisChairman of the Board/Director
John SagartzChief Strategy Officer/Director
Wendy PerrowDirector
R. NeffDirector
Richard JohnsonDirector
Philip DowningSenior VP, Divisional
Bioanalytical Systems, Inc. (BASi) is a contract research organization (CRO) that provides drug discovery and development services to the pharmaceutical industry. BASi also sells analytical instruments to the pharmaceutical development and contract research industries, enabling drug developers to b.....
See More

Auditor: RSM US LLP
Legal Advisor: Ice Miller LLP
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue26,346,00024,242,00020,441,00022,698,00024,584,00022,068,000
    Cost of Revenue18,230,00016,545,00016,016,00015,209,00016,622,00015,013,000
    Gross Margin % - 31.7521.6532.9932.3931.97
    R&D Expense596,000465,000496,000715,000658,000454,000
    Operating Income14,0001,278,000(2,069,000)304,000708,000830,000
    Operating Margin % - 5.27-10.124.002.883.76
    SGA Expense7,506,0005,954,0005,998,0006,470,0006,596,0005,771,000
    Net Income(194,000)884,000(3,230,000)1,099,000(1,070,000)773,000
    Earnings Per Share-0.020.11-0.400.14-0.130.10
    Dividends - - - - - -
    Book Value Per Share1.060.900.771.181.031.03
    Operating Cash Flow3,487,0001,236,0001,060,0002,104,0001,684,0001,519,000
    Capital Expenditure1,317,000347,0001,256,0001,467,000490,0008,000
    Free Cash Flow2,170,000889,000(196,000)637,0001,194,0001,511,000
Profitability
    EBITDA1,895,0002,963,000(1,289,000)2,810,0001,022,0003,161,000
    Return on Assets % - 4.25-14.374.62-4.332.94
    Return on Equity % - 12.90-40.8412.28-12.999.44
    Net Margin % - 3.65-15.804.84-4.353.50
    Assets Turnover - 1.170.910.951.000.84
    Financial Leverage - 2.753.372.502.853.15
Brands, Divisions and Affiliates Top Salaries
Smithers Avanza Toxicology Services
NameTitleSalary (US$)Bonus (US$)
Philip DowningSenior VP, Divisional201,2500
James BourdageVice President, Divisional178,6020
Jill BlumhoffCFO/Vice President, Divisional166,8750
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: